Risk of discontinuation of Advanced Therapy Medicinal Products clinical trials
{{output}}
Objective: Advanced therapy medicinal products (ATMPs) constitute a class of innovative products that encompasses gene therapy, somatic cell therapy, and tissue-engineered products (TEP). There is an increased investment of comme... ...